Researchers have developed a two-step approach using whole exome sequencing to predict whether cancer patients will respond to immunotherapy. Immunotherapies, such as immune checkpoint inhibitors, have transformed the treatment of advanced cancers. However, these therapies have not worked for everyone. To better predict who will benefit from immunotherapy, scientists have developed various biomarkers that help anticipate immunotherapy treatment response. Several